Michael D. West
50Patents
17h-index
38Co-inventors
84Inventor score
Filing activity: Jun 21, 1982 → Feb 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6800480B1 | Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture | Chemistry; Metallurgy | 202 | Expired |
| US5489508A | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity | Emerging Cross-Sectional Technologies | 142 | Expired |
| US5645986A | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity | Chemistry; Metallurgy | 55 | Expired |
| US5639613A | Methods for cancer diagnosis and prognosis | Chemistry; Metallurgy | 53 | Expired |
| US5874444A | Poly (ADP-ribose) polymerase inhibitors to treat diseases associated with cellular senescence | Human Necessities | 49 | Expired |
| US7413902B2 | Feeder-free culture method for embryonic stem cells or primate primordial stem cells | Chemistry; Metallurgy | 36 | Expired |
| US5695932A | Telomerase activity assays for diagnosing pathogenic infections | Emerging Cross-Sectional Technologies | 31 | Expired |
| US5686245A | Methods for screening for agents which modulate telomere length | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5648215A | Telomerase diagnostic methods | Chemistry; Metallurgy | 26 | Expired |
| US5686306A | Methods and reagents for lengthening telomeres | Chemistry; Metallurgy | 25 | Expired |
| US5589483A | Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence | Human Necessities | 25 | Expired |
| US6368789B1 | Screening methods to identify inhibitors of telomerase activity | Emerging Cross-Sectional Technologies | 22 | Expired |
| US8685386B2 | Methods and compositions for in vitro and in vivo chondrogenesis | Chemistry; Metallurgy | 20 | Active |
| US5707795A | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6194206A | Use of oligonucleotide telomerase inhibitors to reduce telomere length | Emerging Cross-Sectional Technologies | 19 | Expired |
| US7838727B2 | Derivation of embryonic stem cells | Chemistry; Metallurgy | 17 | Expired |
| US6007989A | Methods of screening for compounds that derepress or increase telomerase activity | Chemistry; Metallurgy | 17 | Expired |
| US5693474A | Methods for cancer diagnosis and prognosis | Chemistry; Metallurgy | 15 | Expired |
| US5744300A | Methods and reagents for the identification and regulation of senescence-related genes | Chemistry; Metallurgy | 13 | Expired |
| US7910369B2 | Culture systems for ex vivo development | Chemistry; Metallurgy | 10 | Active |
| US4569366A | Position indicator for rising stem valve | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5830644A | Method for screening for agents which increase telomerase activity in a cell | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7135171B2 | Endothelial precursor cells for enhancing and restoring vascular function | Chemistry; Metallurgy | 8 | Expired |
| US9732128B2 | Methods of modifying transcriptional regulatory networks in stem cells | Chemistry; Metallurgy | 8 | Active |
| US6391554B1 | Detecting cancerous conditions by assaying for telomerase activity | Chemistry; Metallurgy | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.